Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes

Eyal Leshem; Kristin Nelson; Benjamin Alan Lopman

doi:10.1016/S2213-2600(21)00413-6

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes

Eyal Leshem, Kristin Nelson, Benjamin Alan Lopman

Clinical Departments

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	1354-1356
Number of pages	3
Journal	The Lancet Respiratory Medicine
Volume	9
Issue number	12
DOIs	https://doi.org/10.1016/S2213-2600(21)00413-6
State	Published - Dec 2021

Access to Document

10.1016/S2213-2600(21)00413-6

Cite this

@article{e1ec1e534e314cd2aebed5e9e0dba9c0,

title = "Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes",

author = "Eyal Leshem and Kristin Nelson and Lopman, {Benjamin Alan}",

note = "Funding Information: EL reports personal fees from Sanofi Pasteur for participation in a global influenza vaccination advisory board, outside the area of work commented on here. BAL and KN were supported by NIH/NIAID R01 AI143875 and NIH/NIGMS R01 GM124280.",

year = "2021",

month = dec,

doi = "10.1016/S2213-2600(21)00413-6",

language = "אנגלית",

volume = "9",

pages = "1354--1356",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "Elsevier Ltd.",

number = "12",

}

TY - JOUR

T1 - Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes

AU - Leshem, Eyal

AU - Nelson, Kristin

AU - Lopman, Benjamin Alan

N1 - Funding Information: EL reports personal fees from Sanofi Pasteur for participation in a global influenza vaccination advisory board, outside the area of work commented on here. BAL and KN were supported by NIH/NIAID R01 AI143875 and NIH/NIGMS R01 GM124280.

PY - 2021/12

Y1 - 2021/12

UR - http://www.scopus.com/inward/record.url?scp=85120162134&partnerID=8YFLogxK

U2 - 10.1016/S2213-2600(21)00413-6

DO - 10.1016/S2213-2600(21)00413-6

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 34599904

AN - SCOPUS:85120162134

SN - 2213-2600

VL - 9

SP - 1354

EP - 1356

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 12

ER -

Severe breakthrough COVID-19 infections in Scotland—implications for immunisation programmes

Access to Document

Other files and links

Cite this